Cargando…
Novel Anti-arrhythmic Medications in the Treatment of Atrial Fibrillation
Atrial fibrillation (AF) is a prevalent condition particularly amongst the elderly, which contributes to both morbidity and mortality. The burden of disease has lead to significant increases in health care utilization and cost in recent years. Treatment of Atrial fibrillation consists of either a ra...
Autores principales: | Saklani, Pradyot, Skanes, Allan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492814/ https://www.ncbi.nlm.nih.gov/pubmed/22920483 http://dx.doi.org/10.2174/157340312803760785 |
Ejemplares similares
-
Anti-arrhythmic drugs in atrial fibrillation: tailor-made treatments
por: Capucci, Alessandro, et al.
Publicado: (2023) -
Defining Anti-arrhythmic Efficacy in the Setting of Evolving Concepts About Atrial Fibrillation
por: Reiffel, James A.
Publicado: (2023) -
In silico study of the effects of anti-arrhythmic drug treatment on sinoatrial node function for patients with atrial fibrillation
por: Bai, Jieyun, et al.
Publicado: (2020) -
Clinical and economic outcomes associated with use of anti-arrhythmic drugs versus ablation in atrial fibrillation
por: Ken-Opurum, Jennifer, et al.
Publicado: (2023) -
Atrial Heterogeneity Generates Re-entrant Substrate during Atrial Fibrillation and Anti-arrhythmic Drug Action: Mechanistic Insights from Canine Atrial Models
por: Varela, Marta, et al.
Publicado: (2016)